Mark L Baum, Director and Chief Executive Officer, on May 14, 2026, executed a purchase for 10,000 shares in Harrow (HROW) for $302,000. Following the Form 4 filing with the SEC, Baum has control over a total of 2,996,130 common shares of the company, with 2,996,130 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1360214/000149315226023321/xslF345X05/ownership.xml
John W Kozarich, Director, on May 01, 2026, sold 2,501 shares in Ligand Pharmaceuticals (LGND) for $563,080. Following the Form 4 filing with the SEC, Kozarich has control over a total of 41,786 common shares of the company, with 41,786 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/xslF345X05/edgardoc.xml
Frank Porter Stansberry, 10% Owner and Director, on May 12, 2026, executed a purchase for 30,000 shares in Marketwise (MKTW) for $547,400. Following the Form 4 filing with the SEC, Stansberry has control over a total of 331,756 Class A common shares of the company, with 331,756 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1805651/000162828026035297/xslF345X05/wk-form4_1778806744.xml
Akira Takata, Director, on May 12, 2026, sold 1,500 shares in Sitime (SITM) for $1,291,290. Following the Form 4 filing with the SEC, Takata has control over a total of 12,234 common shares of the company, with 12,234 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1451809/000179185526000004/xslF345X05/wk-form4_1778806401.xml